Nano drug-carrying system, its preparation method, pharmaceutical composition and application in treating cancer

A nano-drug-loading and nano-carrier technology, applied in drug combinations, pharmaceutical formulations, anti-tumor drugs, etc., can solve problems such as aggravation of EMT, invasion and metastasis, and achieve the effect of preventing invasion and metastasis.

Active Publication Date: 2020-09-15
HUAZHONG UNIV OF SCI & TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The purpose of the present invention is to overcome or alleviate the problems of chemotherapeutic drugs, especially DOX, which cause the aggravation of EMT degree and easy occurrence of invasion and metastasis, so as to better exert the therapeutic effect of chemotherapeutic drugs, especially DOX

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nano drug-carrying system, its preparation method, pharmaceutical composition and application in treating cancer
  • Nano drug-carrying system, its preparation method, pharmaceutical composition and application in treating cancer
  • Nano drug-carrying system, its preparation method, pharmaceutical composition and application in treating cancer

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0087] The preparation method of the HES-PLA graft copolymer can refer to, for example, the method disclosed in the patent application CN103467753A, which is incorporated herein by reference in its entirety.

[0088] According to a preferred embodiment, the preparation method of the nano drug-carrying system using HES-PLA grafted polymer as a carrier of the present invention includes:

[0089] It includes the following steps:

[0090] (1) Dissolve PLA and activate its terminal carboxyl group: Add the catalyst N-N'-dicyclohexylcarbodiimide and 4-dimethylaminopyridine to the carboxyl-terminated PLA, with anhydrous dimethyl sulfoxide as the solvent, 50 React for 25 to 45 minutes at ~70°C to completely dissolve it to obtain PLA with activated terminal carboxyl groups; the molecular weight of the PLA is 10-30kDa, preferably 10kDa, and the PLA, N-N'-dicyclohexyl carbon two The molar ratio of imine and 4-dimethylaminopyridine is 1:4:2;

[0091] (2) Dissolving HES: Under nitrogen protection,...

Embodiment 1

[0155] Example 1 Preparation of HES-PLA copolymer

[0156] Weigh 0.5g HES (Hua Keda Life Science & Technology Co., Ltd., hydroxyethylation rate is 0.5), put it in a drying oven at 105°C for 2h, take it out, and dissolve it in 20mL DMSO (60°C). At the same time, PLA (Mw 5kDa, Jinan Daigang Bioengineering Co., Ltd.), dicyclohexylcarbodiimide and dimethylaminopyridine were dissolved in 10 mL DMSO at a molar ratio of 1:4:2. After the two solutions were mixed, they were placed in a round-bottomed flask, protected by nitrogen, the temperature of the oil bath was maintained at 60°C, and the reaction was stirred for 24 hours. After the reaction is over, the product is collected, placed in a dialysis bag with an intercepted molecular weight of 3500, and dialyzed with ultrapure water for 3 days. After the dialysis product was freeze-dried, dichloromethane was added to purify it through a Soxhlet extractor (70°C, 24h) to remove unreacted PLA. The product obtained after extraction was vacu...

Embodiment 2

[0157] Example 2 Preparation of Nanoparticles (DOX / LY@ Nanoparticles) containing DOX and LY2157299 (hereinafter referred to as LY)

[0158] Weigh 6 mg of DOX hydrochloride (Beijing Huafeng Lianbo Co., Ltd.) and suspend and disperse it in 1 mL of chloroform. According to the molar ratio DOX: triethylamine=1:3, triethylamine was added to the suspension. After the suspension was sonicated for 1 hour, it was centrifuged at 3000 rpm for 10 minutes, and the supernatant was taken, which was the DOX trichloromethane solution with hydrochloric acid removed. Weigh 12 mg of LY and add it to the DOX chloroform solution, vortex and mix until there are no obvious particles in the solution.

[0159] Weigh 30 mg of the HES-PLA copolymer prepared in Example 1 and dissolve it in 20 mL of ultrapure water. In an ice bath, add the above 1 mL DOX / LY trichloromethane solution dropwise to the HES-PLA aqueous solution. During the dripping process, the solution was emulsified (power: 200W, working time: ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention relates to a co-encapsulated nanometer drug carrying system, a pharmaceutical composition containing the same, a drug system containing the same and application of the co-encapsulated nanometer drug carrying system to cancer treatment and further relates to a method for preparing the nanometer drug carrying system. The invention belongs to the field of nanometer drugs and particularly relates to the field of co-encapsulated nanometer drugs. The invention specifically provides the co-encapsulated nanometer drug carrying system which comprises a nanometer carrier, a TGF-beta inhibitor and DOX, wherein the TGF-beta inhibitor and the DOX are co-encapsulated in the nanometer carrier. Further, the effect of killing tumors in a body and inhibiting tumor invasion and metastasis is realized.

Description

Technical field [0001] The invention relates to a nano medicine, in particular to a co-encapsulated nano medicine. Background technique [0002] Tumors have become a worldwide public health problem and seriously threaten people's health. The latest statistics show that in 2017, the number of new cancer patients in the United States will reach 1.69 million, and the number of deaths due to cancer will also increase to 600,000. In China, according to statistics, the number of new cancer patients reached 4.3 million in 2015, and the number of deaths due to cancer reached 2.81 million. With the intensification of population aging, deterioration of the ecological environment and changes in lifestyles (smoking, obesity, etc.), the above data is still showing an upward trend year by year. Statistics from the Ministry of Health show that since 2010, tumors have replaced cardiovascular diseases and have become the leading cause of death for Chinese residents. [0003] Chemotherapy is curr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/107A61K9/127A61K47/36A61K45/06A61K31/704A61K31/4709A61P35/00
CPCA61K9/1075A61K9/127A61K31/4709A61K31/704A61K45/06A61K47/36A61K2300/00
Inventor 李子福杨祥良朱艳红徐辉碧周庆
Owner HUAZHONG UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap